Archive for the ‘harvard’ Category
Age has retracted a 2012 article by a group of scientists from the National Institutes of Health and Brigham and Women’s Hospital in Boston after an NIH inquiry turned up evidence of data manipulation in the work.
The article, “Aging decreases rate of docosahexaenoic acid synthesis-secretion from circulating unesterified α-linolenic acid by rat liver,” came from the lab of Stanley Rapoport, chief of the brain physiology and metabolism section of the National Institute on Aging.
Circulation has retracted a 2012 study by a group of Harvard heart specialists over concerns of corrupt data, and the university is investigating. The group was led by Piero Anversa, a leading cardiologist, and Joseph Loscalzo — who will be familiar to readers of Circulation as the editor in chief of that journal. (Anversa’s also on the editorial board).
An international team of researchers from the NIH, Harvard, the University of Michigan, and two Chinese universities — Fourth Military Medical University and China Medical University — has retracted their 2012 paper in Nature after they — and a number of other groups — were unable to reproduce the key results.
The original abstract for “The NAD-dependent deacetylase SIRT2 is required for programmed necrosis” said that the findings
implicate SIRT2 as an important regulator of programmed necrosis and indicate that inhibitors of this deacetylase may constitute a novel approach to protect against necrotic injuries, including ischaemic stroke and myocardial infarction.
Blood has retracted two 2013 illustrations of red cells by researchers from South Africa and the United States because, somewhat confusingly, they didn’t conform to the journal’s criteria for publishing such material.
Harvard student publication retracts article saying Jews deserve punishment because “they killed Jesus”
(We’ll do a few conflict of interest disclosures, if just for the hell — oops — of it: Harvard is Ivan’s alma mater, and both of us are well, Jews. We note, however, that the Ichthus was not around in Ivan’s Harvard days, and neither of us was around when the events involving Jesus described in this post occurred.)
Martin Biosse-Duplan, a former Harvard dental school research fellow found by the Office of Research Integrity to have falsified results has had the two papers in question retracted.
Last week was a busy one at the U.S. Office of Research Integrity (ORI), at least judging by how many cases they posted. There were sanctions against researchers at Ohio State, Texas Tech, and the Gladstone Institutes, as we reported. And it turns out there was another case closed, of a former Harvard dental school research fellow, The Scientist reports.
According to the ORI, Martin Biosse-Duplan “engaged in research misconduct in research supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), grant R01 AR054450.”
The misconduct involved a lab presentation and two published abstracts: Read the rest of this entry »
In August of last year, Mladen Pavičić, chair of physics at the University of Zagreb’s Faculty of Civil Engineering, published a paper in Physical Review Letters on quantum teleportation, “Near-Deterministic Discrimination of All Bell States with Linear Optics.”
Just six days later, after hearing from a physicist in China, Pavičić — who is also affiliated with Harvard’s physics department — submitted a correction, which ran on the journal’s site in November. The correction begins: Read the rest of this entry »
The work of Sam W. Lee, a cancer biologist at Harvard and Massachusetts General Hospital, has come under fire at Science Fraud lately over concerns about the possible reuse of images in his group’s published studies.
Turns out there’s some there, there after all. The journal Current Biology has issued a pretty thorny correction for one of Lee’s 2006 articles, “RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress,” citing multiple issues with its figures: Read the rest of this entry »